OKRA.ai wins prestigious Deloitte Fast 50 Women in Leadership Award

24th November 2022

OKRA.ai logo

OKRA.ai wins prestigious Deloitte Fast 50 Women in Leadership Award

CAMBRIDGE, UK - 24 November 2022 - OKRA.ai ranked 9th in Deloitte’s fastest-growing tech companies in the UK 2022

We are delighted to inform you that OKRA.ai is the winner of the Deloitte UK Fast 50 Women in leadership award. OKRA.ai also ranked 9th as one of the fastest growing tech companies in the UK with 4,227% growth over the last four years!

This award recognised OKRA.ai not only for the commercial and financial achievements, but also as a beacon for the empowerment of women in leadership. OKRA.ai technology focuses on empowering individuals with AI capabilities across life science companies. Whilst leading OKRA.ai, Dr Bouarfa has also always been an advocate for diversity, women's power and challenging the status quo.

“We’ve been playing music without sheets and now we’re writing it,” said Loubna Bouarfa. “Our technology supports pharmaceutical companies to bring the right drug to the right patient at speed. We help uncover business-critical insights that directly impact physicians and patients; so far, we’re only scratching the surface.”

To know more about OKRA.ai and their growth path in becoming one of the fastest growing tech companies in the UK please read the case study.

About OKRA.ai

OKRA.ai, founded in 2015, is a leading artificial intelligence (AI) company transforming life sciences operations through the use of AI solutions. OKRA.ai has created a state of the art, AI solution suite that compiles healthcare data from multiple sources, with coverage across hundreds of therapeutic areas, thousands of clinical trials and publications, millions of medically relevant free text and billions of data points that are specific to patient demographics. OKRA.ai combines advanced AI with a hybrid explainability to deliver real-time insights, including predictions and suggestions to support commercial engagement, help identify medical unmet needs, and assist market access teams with regulatory submissions for new assets when considering future price and benefit decisions.

OKRA.ai’s systems support life sciences companies to better enable the drive of personalised medicine across the globe.

To find out more about OKRA.ai or request a demo click here.

Request a Demo

Do you want to learn more?
Leave your email here and we will contact you.

For any other requests including press and speaking opportunities, please email hello@okra.ai